{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:39:09Z","timestamp":1794530349183,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2022 Scientific Research Fund of Anhui Medical University","award":["2022xkj195"],"award-info":[{"award-number":["2022xkj195"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00228-026-03996-x","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:11:38Z","timestamp":1770361898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early albumin infusion and mortality in ICU patients with HFpEF: a target trial emulation study"],"prefix":"10.1007","volume":"82","author":[{"given":"Zhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nin-jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"3996_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM (2017) Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 14:591\u2013602. https:\/\/doi.org\/10.1038\/nrcardio.2017.65","journal-title":"Nat Rev Cardiol"},{"key":"3996_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"SJ Shah","year":"2020","unstructured":"Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R et al (2020) Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute working group summary. Circulation 141:1001\u201326. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041886","journal-title":"Circulation"},{"key":"3996_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","volume":"329","author":"MM Redfield","year":"2023","unstructured":"Redfield MM, Borlaug BA (2023) Heart failure with preserved ejection fraction: a review. JAMA 329:827\u2013838. https:\/\/doi.org\/10.1001\/jama.2023.2020","journal-title":"JAMA"},{"key":"3996_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014716","volume":"9","author":"SB Prenner","year":"2020","unstructured":"Prenner SB, Pillutla R, Yenigalla S, Gaddam S, Lee J, Obeid MJ et al (2020) Serum albumin is a marker of myocardial fibrosis, adverse pulsatile aortic hemodynamics, and prognosis in heart failure with preserved ejection fraction. J Am Heart Assoc 9:e014716. https:\/\/doi.org\/10.1161\/JAHA.119.014716","journal-title":"J Am Heart Assoc"},{"key":"3996_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ehf2.12128","volume":"4","author":"A Ancion","year":"2017","unstructured":"Ancion A, Allepaerts S, Oury C, Gori A-S, Pi\u00e9rard LA, Lancellotti P (2017) Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail 4:138\u2013145. https:\/\/doi.org\/10.1002\/ehf2.12128","journal-title":"ESC Heart Fail"},{"key":"3996_CR6","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2505177","volume":"25","author":"J Su","year":"2024","unstructured":"Su J, Su K, Song Y, Hao L, Wang Y, Chen S et al (2024) Clinical characteristics and prognosis of heart failure with preserved ejection fraction across diverse ejection fraction ranges. Rev Cardiovasc Med 25:177. https:\/\/doi.org\/10.31083\/j.rcm2505177","journal-title":"Rev Cardiovasc Med"},{"key":"3996_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101395","volume":"3","author":"O Zainul","year":"2024","unstructured":"Zainul O, Marshall D, Lau JD, Kelly B, Zarzuela K, Damluji A et al (2024) Comparison of physical frailty assessments in heart failure with preserved ejection fraction. JACC: Advances 3:101395. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101395","journal-title":"JACC: Advances"},{"key":"3996_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejim.2024.12.024","volume":"133","author":"P Ll\u00e0cer","year":"2025","unstructured":"Ll\u00e0cer P, Croset F, de la Espriella R, Garc\u00eda M, Mi\u00f1ana G, Campos J et al (2025) The impact of hypoalbuminemia on the long-term prognosis of patients with acute heart failure: the modifying role of carbohydrate antigen 125. Eur J Intern Med 133:71\u20137. https:\/\/doi.org\/10.1016\/j.ejim.2024.12.024","journal-title":"Eur J Intern Med"},{"key":"3996_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/cc13991","volume":"18","author":"J-L Vincent","year":"2014","unstructured":"Vincent J-L, Russell JA, Jacob M, Martin G, Guidet B, Wernerman J et al (2014) Albumin administration in the acutely ill: what is new and where next? Crit Care 18:231. https:\/\/doi.org\/10.1186\/cc13991","journal-title":"Crit Care"},{"key":"3996_CR10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1305727","journal-title":"N Engl J Med"},{"key":"3996_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM (2016) Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 183:758\u2013764. https:\/\/doi.org\/10.1093\/aje\/kwv254","journal-title":"Am J Epidemiol"},{"key":"3996_CR12","doi-asserted-by":"publisher","unstructured":"La GD, Of GR, Rw C, Ma L H. Electronic medical records can be used to emulate target trials of sustained treatment strategies. J Clin Epidemiol 2018;96. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.11.021","DOI":"10.1016\/j.jclinepi.2017.11.021"},{"key":"3996_CR13","doi-asserted-by":"publisher","unstructured":"Ma H, W W, De L Target trial emulation: A framework for causal inference from observational data. JAMA 2022;328. https:\/\/doi.org\/10.1001\/jama.2022.21383","DOI":"10.1001\/jama.2022.21383"},{"key":"3996_CR14","unstructured":"Target Trial Emulation for Observational Studies (2025) - Potential and Pitfalls - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/39588897\/"},{"key":"3996_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S et al (2023) MIMIC-IV, a freely accessible electronic health record dataset. Sci Data 10:1. https:\/\/doi.org\/10.1038\/s41597-022-01899-x","journal-title":"Sci Data"},{"key":"3996_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02797-1","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Zhao Y-T (2022) Albumin infusion in hospitalized patients with acute heart failure: a retrospective cohort study. BMC Cardiovasc Disord 22:358. https:\/\/doi.org\/10.1186\/s12872-022-02797-1","journal-title":"BMC Cardiovasc Disord"},{"key":"3996_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/FJC.0000000000001513","volume":"83","author":"M Lai","year":"2024","unstructured":"Lai M, Lam JC, Radosevich JJ, Patanwala AE, Vijayakrishnan R (2024) Levels of albumin and impact on loop diuretic and albumin co-administration in heart failure. J Cardiovasc Pharmacol 83:271\u2013275. https:\/\/doi.org\/10.1097\/FJC.0000000000001513","journal-title":"J Cardiovasc Pharmacol"},{"key":"3996_CR18","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.clnu.2017.07.009","volume":"37","author":"E Ramiro-Ortega","year":"2018","unstructured":"Ramiro-Ortega E, Bonilla-Palomas JL, G\u00e1mez-L\u00f3pez AL, Moreno-Conde M, L\u00f3pez-Ib\u00e1\u00f1ez MC, Alhambra-Exp\u00f3sito R et al (2018) Nutritional intervention in acute heart failure patients with undernutrition and normalbuminemia: a subgroup analysis of PICNIC study. Clin Nutr 37:1762\u20134. https:\/\/doi.org\/10.1016\/j.clnu.2017.07.009","journal-title":"Clin Nutr"},{"key":"3996_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","volume":"237","author":"J-L Vincent","year":"2003","unstructured":"Vincent J-L, Dubois M-J, Navickis RJ, Wilkes MM (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237:319\u2013334. https:\/\/doi.org\/10.1097\/01.SLA.0000055547.93484.87","journal-title":"Ann Surg"},{"key":"3996_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-92","volume":"13","author":"B Phakdeekitcharoen","year":"2012","unstructured":"Phakdeekitcharoen B, Boonyawat K (2012) The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study. BMC Nephrol 13:92. https:\/\/doi.org\/10.1186\/1471-2369-13-92","journal-title":"BMC Nephrol"},{"key":"3996_CR21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/cells4040622","volume":"4","author":"M Duffy","year":"2015","unstructured":"Duffy M, Jain S, Harrell N, Kothari N, Reddi AS (2015) Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies. Cells 4:622\u2013630. https:\/\/doi.org\/10.3390\/cells4040622","journal-title":"Cells"},{"key":"3996_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010055","volume":"14","author":"K Watanabe","year":"2025","unstructured":"Watanabe K, Kinoshita H, Okamoto T, Sugiura K, Kawashima S, Kimura T (2025) Antioxidant properties of albumin and diseases related to obstetrics and gynecology. Antioxidants 14:55. https:\/\/doi.org\/10.3390\/antiox14010055","journal-title":"Antioxidants"},{"key":"3996_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1441-2772(23)00394-0","volume":"22","author":"S Bihari","year":"2020","unstructured":"Bihari S, Bannard-Smith J, Bellomo R (2020) Albumin as a drug: its biological effects beyond volume expansion. Crit Care Resusc 22:257\u2013265. https:\/\/doi.org\/10.1016\/S1441-2772(23)00394-0","journal-title":"Crit Care Resusc"},{"key":"3996_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cardfail.2011.02.010","volume":"17","author":"S Arques","year":"2011","unstructured":"Arques S, Ambrosi P (2011) Human serum albumin in the clinical syndrome of heart failure. J Card Fail 17:451\u20138. https:\/\/doi.org\/10.1016\/j.cardfail.2011.02.010","journal-title":"J Card Fail"},{"key":"3996_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enter Nutr 43:181\u2013193. https:\/\/doi.org\/10.1002\/jpen.1451","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"3996_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/cc688","volume":"4","author":"TB Pulimood","year":"2000","unstructured":"Pulimood TB, Park GR (2000) Debate: albumin administration should be avoided in the critically ill. Crit Care 4:151\u20135. https:\/\/doi.org\/10.1186\/cc688","journal-title":"Crit Care"},{"key":"3996_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00830-8","volume":"11","author":"S Zhou","year":"2021","unstructured":"Zhou S, Zeng Z, Wei H, Sha T, An S (2021) Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database. Ann Intensive Care 11:42. https:\/\/doi.org\/10.1186\/s13613-021-00830-8","journal-title":"Ann Intensive Care"},{"key":"3996_CR28","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.3390\/ijms22094496","volume":"22","author":"CJ Wiedermann","year":"2021","unstructured":"Wiedermann CJ (2021) Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci 22:4496. https:\/\/doi.org\/10.3390\/ijms22094496","journal-title":"Int J Mol Sci"},{"key":"3996_CR29","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMoa1502826","volume":"372","author":"YM Arabi","year":"2015","unstructured":"Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones G et al (2015) Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med 372:2398\u2013408. https:\/\/doi.org\/10.1056\/NEJMoa1502826","journal-title":"N Engl J Med"},{"key":"3996_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","volume":"73","author":"K Omote","year":"2022","unstructured":"Omote K, Verbrugge FH, Borlaug BA (2022) Heart failure with preserved ejection fraction: mechanisms and treatment strategies. Annu Rev Med 73:321\u2013337. https:\/\/doi.org\/10.1146\/annurev-med-042220-022745","journal-title":"Annu Rev Med"},{"key":"3996_CR31","doi-asserted-by":"publisher","first-page":"155932582413030","DOI":"10.1177\/15593258241303040","volume":"22","author":"K Zhang","year":"2024","unstructured":"Zhang K, Shi Y, Han Y, Cai TY, Gu FM, Gu ZX et al (2024) J-Shaped association between respiratory rate and In-Hospital mortality in acute myocardial infarction patients complicated by congestive heart failure in intensive care unit. Dose Response 22:15593258241303040. https:\/\/doi.org\/10.1177\/15593258241303040","journal-title":"Dose Response"},{"key":"3996_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146810","volume":"26","author":"P Gajewski","year":"2025","unstructured":"Gajewski P, Wilk MM, Aleksandrowicz K, Ponikowska B, Zymli\u0144ski R (2025) Lactate in heart failure. Int J Mol Sci 26:6810. https:\/\/doi.org\/10.3390\/ijms26146810","journal-title":"Int J Mol Sci"},{"key":"3996_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2459\/JCM.0000000000001518","volume":"24","author":"Z Yu","year":"2023","unstructured":"Yu Z, Zhu B, Ma J, Guan Y, Zhou Y, Li H et al (2023) Albumin use and mortality among intensive care patients with acute heart failure: a retrospective study. J Cardiovasc Med (Hagerstown) 24:578\u201384. https:\/\/doi.org\/10.2459\/JCM.0000000000001518","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"3996_CR34","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.21037\/jtd-22-648","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Ling Y, Yuan X, Liu X, Huang W, Chen Q et al (2022) Impact of albumin infusion on prognosis of intensive care unit patients with congestive heart failure-hypoalbuminemia overlap: a retrospective cohort study. J Thorac Dis 14:2235\u201346. https:\/\/doi.org\/10.21037\/jtd-22-648","journal-title":"J Thorac Dis"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-03996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-03996-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-03996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:52:41Z","timestamp":1773309161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-03996-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-03996-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted using the Medical Information Mart for Intensive Care IV (MIMIC-IV, version 2.2) database, which is a publicly available, de-identified critical care database. Access to the database was granted after completion of the required training and certification. As all patient data are de-identified and publicly available, ethical approval and informed consent were waived. The use of MIMIC-IV complies with the ethical standards of the Massachusetts Institute of Technology (MIT) and the Beth Israel Deaconess Medical Center (BIDMC). This study was conducted in accordance with the Declaration of Helsinki (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"69"}}